There are also randomized control trials (RCTs) demonstrating that FMT contributed to weight loss in obese patients and improvement of insulin sensitivity in MetS patients, and no related adverse events were found, so FMT could at least prevent HFpEF by treating MetS [128,129]. Here, INS is linked to metabolic syndrome.